Oramed Pharmaceuticals Inc Market Cap ($149.38 Million)

$149.38 Million USD · Rank #17504

Market Cap & Net Worth: Oramed Pharmaceuticals Inc (ORMP)

Oramed Pharmaceuticals Inc market cap. Oramed Pharmaceuticals Inc (NASDAQ:ORMP) has a market capitalization of $149.38 Million ($149.38 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #17504 globally and #4152 in its home market, demonstrating a -3.15% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oramed Pharmaceuticals Inc's stock price $4.00 by its total outstanding shares 40926081 (40.93 Million). Also see cash flow conversion of Oramed Pharmaceuticals Inc for how efficiently the company converts equity into cash flow.

Oramed Pharmaceuticals Inc Market Cap History (2015–2026)

Oramed Pharmaceuticals Inc market cap history from 2015 to 2026. Data shows change from $349.92 Million to $163.70 Million (-5.15% CAGR). Check today's stock price for Oramed Pharmaceuticals Inc for real-time trading data and today's change.

Index Memberships

Oramed Pharmaceuticals Inc is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NASDAQ Health Care IXHC	$2.60 Trillion	0.01%	#477 of 976
NASDAQ Composite IXIC	$39.84 Trillion	0.00%	#1703 of 3165

Weight: Oramed Pharmaceuticals Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Oramed Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Oramed Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Oramed Pharmaceuticals Inc annual equity growth to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

58.32x

Oramed Pharmaceuticals Inc's market cap is 58.32 times its annual revenue

Industry average: 4493.50x Lower than industry average

Latest Price to Earnings (P/E) Ratio

1.82x

Oramed Pharmaceuticals Inc's market cap is 1.82 times its annual earnings

Industry average: 1.51x Higher than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$250.47 Million	$641.00K	-$10.96 Million	390.75x	N/A
2017	$368.33 Million	$2.46 Million	-$10.48 Million	149.97x	N/A
2018	$122.78 Million	$2.45 Million	-$12.73 Million	50.13x	N/A
2019	$210.77 Million	$2.70 Million	-$14.36 Million	77.98x	N/A
2020	$173.53 Million	$2.71 Million	-$11.51 Million	64.03x	N/A
2021	$584.42 Million	$2.70 Million	-$22.24 Million	216.21x	N/A
2022	$492.34 Million	$2.70 Million	-$37.76 Million	182.15x	N/A
2023	$94.54 Million	$1.34 Million	$5.53 Million	70.55x	17.11x
2025	$116.64 Million	$2.00 Million	$64.05 Million	58.32x	1.82x

Competitor Companies of ORMP by Market Capitalization

Companies near Oramed Pharmaceuticals Inc in the global market cap rankings as of November 4, 2026. Also see how large is Oramed Pharmaceuticals Inc's balance sheet for a full breakdown of the balance sheet.

Key companies related to Oramed Pharmaceuticals Inc by market ranking:

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#180	Vertex Pharmaceuticals Inc	NASDAQ:VRTX	$130.90 Billion	$553.15
#372	Regeneron Pharmaceuticals Inc	NASDAQ:REGN	$76.14 Billion	$961.26
#411	CSL Ltd	AU:CSL	$69.05 Billion	AU$201.16
#497	Moderna Inc	NASDAQ:MRNA	$54.14 Billion	$220.83

Market Capitalization of Oramed Pharmaceuticals Inc (2015–2026)

Market capitalization of Oramed Pharmaceuticals Inc from 2015 to today. Between 2015 and today, Oramed Pharmaceuticals Inc's market cap moved from $349.92 Million to $ 163.70 Million, with a yearly change of -5.15%.

Year	Market Cap	Change (%)
2026	$163.70 Million	+40.35%
2025	$116.64 Million	+17.77%
2024	$99.04 Million	+4.76%
2023	$94.54 Million	-80.80%
2022	$492.34 Million	-15.76%
2021	$584.42 Million	+236.79%
2020	$173.53 Million	-17.67%
2019	$210.77 Million	+71.67%
2018	$122.78 Million	-66.67%
2017	$368.33 Million	+47.06%
2016	$250.47 Million	-28.42%
2015	$349.92 Million	--

End of Day Market Cap According to Different Sources

On Nov 3rd, 2026 the market cap of Oramed Pharmaceuticals Inc was reported to be:

Source	Market Cap
Yahoo Finance	$149.38 Million USD
MoneyControl	$149.38 Million USD
MarketWatch	$149.38 Million USD
marketcap.company	$149.38 Million USD
Reuters	$149.38 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Oramed Pharmaceuticals Inc

NASDAQ:ORMP USA Biotechnology

Market Cap

$163.70 Million

Market Cap Rank

#17504 Global

#4152 in USA

Share Price

$4.00

Change (1 day)

-2.68%

52-Week Range

$2.19 - $5.34

All Time High

$29.75